Obesity is a Public Health Epidemic in the U.S. — The Case for GLP-1 Coverage, Affordability and Equity
“If the U.S. were sensible, weight management would be treated as a public health issue,” David Cutler writes in the JAMA Health Forum dated August 15, 2024. Dr. Cutler, distinguished economics professor at Harvard, talks about “the pathology of U.S. health care” citing the example of weight loss medications — in short, the uptake of GLP-1 drugs to address Type 2 diabetes first, and subsequently obesity. Dr. Cutler notes that the price of these drugs in the U.S. “far exceeds” that of other countries: specifically, 9 times that of the prices in Germany and the Netherlands
A Health Consumer Bill of Rights: Assuring Affordability, Access, Autonomy, and Equity
Let’s put “health” back into the U.S. health care system. That’s the mantra coming out of this week’s annual Capitol Conference convened by the National Association of Benefits and Insurance Professionals (NABIP). (FYI you might know of NABIP by its former acronym, NAHU, the National Association of Health Underwriters). NABIP, whose members represent professionals in the health insurance benefits industry, drafted and adopted a new American Healthcare Consumer Bill of Rights launched at the meeting. While the digital health stakeholder community is convening this week at VIVE in Los Angeles to share innovations in health tech, NABIP
Rebel Health: The Personal and Professional Passion of Susannah Fox
A “rebel” is both a noun and a verb. As a noun, Merriam-Webster tells us that a rebel is a person who opposes or takes up arms against a government or a ruler. As a verb, “to rebel” is to oppose or disobey one in authority or control, or otherwise renounce and resist by force the authority of one’s government.” An additional definition of the verb is, “to feel or exhibit anger or revulsion.” If you’ve been a patient facing a diagnosis of an illness, whether rare or common, you may well have felt these various feelings stirring inside your self.
Your Grocery Store as Health/Care Destination: Welcome Kroger to the Clinical Trials Community
Our grocery stores were essential touchpoints for us during the COVID-19 lockdown era and thereafter, addressing our basic needs for food and medicines and even social health from early 2020 and since. Grocery stores have been morphing into health/care destinations for the past decade, in the best cases bolstering nutrition, supporting medication adherence and patient outcomes, and helping us curate healthy grocery carts with nutritionists as part of the store pharmacy team. Now Kroger continues to expand its health/care footprint and capabilities, becoming a clinical trials channel as announced in its January 24th press
Our Homes as HealthQuarters – Finding Health and Well-Being at CES 2023
For over ten years, digital health technology has been a fast-growing area at the annual CES, the largest convention covering consumer electronics in the world. When the meet-up convenes over 100,000 tech-folk in Las Vegas at the start of 2023, we’ll see even more health and self-care tools and services at #CES23 — along with new-new things displayed in aisles well outside of the physical space on the Las Vegas Convention Center map labeled “digital health” at this year’s CES in the North Hall. Some context: my company has been a member
Show Me The Evidence and The ROI: Digital Health Investing in 2023 via GSR Ventures
With valuations of digital health companies expected to decline in 2023, investors in the sector are Missourian in spirit in “Show Me” mode: here, it’s all about the clinical evidence and ROI, according to a survey from GSR Ventures. conducted among over 50 major digital health venture capital investors. Most of the 50+ responses to the survey expect that in 2023, valuations for digital health companies will decrease by over 20%: that’s a net of 83% including 60% expecting valuations to fall 20-40%, and 23% anticipating declines of over 40% of valuations in the next
The Evolution of a Patient Ambassador – Learning from Stacy Hurt
“I am a health care executive who happens to be a patient, caregiver, and advocate,” Stacy Hurt explained to me in a Zoom chat we shared on 31 May. I asked her to meet with me to discuss her professional news update: being appointed Parexel’s first Patient Ambassador. My Zoom invitation to Stacy was a very convenient excuse for me to catch up with a friend in the field: we have known each other since Stacy started to grow her health-social media presence on Twitter. And that involvement in
What Person-Centered Interoperability Looks Like: Seqster
He had me at the statement, “I believe health data is medicine.” Those were the words of Ardy Arianpour, CEO and Co-Founder of Seqster, when sharing with me how his company was founded. We met up last week at the DIA Europe 2022 meeting (Drug Information Association) in the cool SQUARE Conference Center in Brussels, Belgium (my current home base for work and life). It was a rare opportunity to sit still with this on-the-go guy with whom an hour spent is the equivalent of three hours with most other folks. Ardy and the team call Seqster “the operating system
I was invited to be a Judge for the upcoming CES 2025 Innovation Awards in the category of digital health and connected fitness. So grateful to be part of this annual effort to identify the best in consumer-facing health solutions for self-care, condition management, and family well-being. Thank you, CTA!
Thank you Team Roche for inviting me to brainstorm patients as health citizens, consumers, payers, and voters in the Healthcare Transformers series.
For the past 15 years, the annual CES conference in Las Vegas has been my go-to meeting for updating my research and network in digital health and consumer-facing electronics that people find meaningful for their well-being, families, and home lives. I'll be back in Vegas in January for a full week of Media Days, one-on-one meetings, and speaking about my perspectives on health consumers.